Showing results (271-280 of 1,011) with videos related to

Sort By:
Pageof 102
Annales De Biologie Clinique|August 30, 2008
[Discrepancy between two methods of D-dimers measurement: one case of human anti-mouse antibody interference]J A Rouvière, J Devignes, E de Maistre, et al.
Annales De Biologie Clinique|May 5, 2009
[Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection]B Frotscher, S Salignac, L Morlon, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 20, 2012
Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral eventsS Richard, M Toussaint-Hacquard, R Fay, et al.
Thrombosis Research|October 25, 2024
Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasmaM Hardy, J Douxfils, O Xhaet, et al.
Thrombosis and Haemostasis|May 6, 2011
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinuxM Wolzt, M M Samama, S Kapiotis, et al.
International Angiology : a Journal of the International Union of Angiology|May 22, 2004
Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episodeE Ombandza-Moussa, M M Samama, M H Horellou, et al.
Thrombosis Research. Supplement|January 1, 1988
Defective thrombolysis due to collagen incorporation in fibrin clotsM Mirshahi, J Soria, H Lu, et al.
Blood|August 1, 1988
Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosisG Nguyen, M H Horellou, E K Kruithof, et al.
Thrombosis and Haemostasis|July 31, 1998
Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparinP Toulon, B Boutière, M H Horellou, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2007
Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generationG T Gerotziafas, A D Petropoulou, E Verdy, et al.
Pageof 102